Anna Petroccione

Age and d<scp>PCR</scp> can predict relapse in <scp>CML</scp> patients who discontinued imatinib: The <scp>ISAV</scp> study

Silvia Mori, Elisabetta Vagge, Philipp le Coutre et al. · American Journal of Hematology · 2015 · 209 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Randomized phase <scp>II</scp> study of danusertib in patients with metastatic castration‐resistant prostate cancer after docetaxel failure

Hielke J. Meulenbeld, Jean Pierre Bleuse, Elio M. Vinci et al. · British Journal of Urology · 2012 · 77 citations

Medicine, Oncology, Pharmacology +17

Outcomes on lithium treatment as a tool for genetic studies in affective disorders

Enrico Smeraldi, Anna Petroccione, M. Gasperini et al. · Journal of Affective Disorders · 1984 · 72 citations

Medicine, Genetics, Psychiatry +15

Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study

P. Schöffski, Benjamin Besse, Thomas Gauler et al. · Annals of Oncology · 2014 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

The search for genetic homogeneity in affective disorders

Enrico Smeraldi, Anna Petroccione, Mariangela Gasperini et al. · Journal of Affective Disorders · 1984 · 31 citations

Life Sciences, Genetics, Psychiatry +11